All News

03:12am Roche acquisition poised to deliver windfall for I Love Lund FW
Apr. 16 Swiss Market Index Extends Losses; Barry Callebaut Plummets MT
Apr. 16 Roche to Buy Cancer-focused Saga Diagnostics for Up to $595 Million MT
Apr. 16 Roche Plans New Trial for Muscular Dystrophy Therapy to Seek EU Approval DJ
Apr. 16 Roche launches new Elevidys study after feedback from European regulator RE
Apr. 14 Pharma sector doubles down on AI amid hopes of slashing costs, timelines RE
Apr. 13 Roche Receives CE Mark for New Elecsys NfL Blood Test to Detect Neuroinflammation in Multiple Sclerosis CI
Apr. 13 Roche's Elecsys NfL Blood Test Gets CE Mark for Neuroinflammation Detection in Multiple Sclerosis MT
Apr. 13 Roche receives CE Mark for new Elecsys Nfl blood test to detect neuroinflammation in multiple sclerosis RE
Apr. 10 Health Care Down on Retreat from Biotech -- Health Care Roundup DJ
Apr. 10 Lineage Cell Therapeutics, Inc. Announces Allogeneic Cell Platform Expands into Islet Therapy for Type 1 Diabetes CI
Apr. 10 ROCHE HOLDINGS AG : UBS reiterates its Buy rating ZD
Apr. 09 C4 Therapeutics, Inc. Enters into New Collaboration Agreement with Roche CI
Apr. 09 C4 Therapeutics, Roche expand partnership with new cancer deal worth over $1 billion RE
Apr. 09 C4 Therapeutics Expands Roche Partnership to Develop Degrader-Antibody Conjugates Against Cancer MT
Apr. 09 C4 Therapeutics expands long-term partnership with Roche through new collaboration agreement focused on discovering and developing Degrader-Antibody Conjugates (DACs) RE
Apr. 08 Zurich Insurance Group Appoints New Vice Chair, Confirms Chairman MT
Apr. 02 Global pharma companies that have publicly announced Trump drug pricing agreements RE
Apr. 01 Explainer: GmbH, NV, KGaA, Plc, SpA, Oyj, SGPS… what are we talking about? Zonebourse
Mar. 31 Drugmakers delay some European launches with a wary eye on Trump's pricing policies RE
Mar. 30 Wall Street ends mostly lower as Middle East conflict weighs RE
Mar. 30 Swiss Market Index Joins European Rally, Shrugs Off Downcast Economic Growth Outlook MT
Mar. 30 Roche receives FDA 510(k) clearance for cobas® c703 and cobas® ise neo RE
Mar. 30 Biogen gets FDA approval for higher dose of genetic disorder drug RE
Mar. 30 Roche Launches the Cobas MPX-E Assay, A New 4-In-1 Donor Screening Test CI
No results for this search